Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

A method was found to visualize hair regrowth and avoid unnecessary side effects from treatments.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.